
Searab L 75mg/20mg Capsule SR
Manufacturer
Curasia Medilabs
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Searab L 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Searab L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. It is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Searab L 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea stomach pain diarrhea flatulence constipation headache weakness and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Searab L 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Searab L 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Searab L 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Searab L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Searab L 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Searab L 75mg/20mg Capsule SR for longer than prescribed.
Related Medicines

Rablet L Capsules

Rabemac LS Capsule

Colosafe-L Capsule SR

Acera-L Capsule SR

Ansuper-Plus Capsule SR

Razo-L Capsule

Veloz L Capsule

Rabonik Plus Capsule SR

Repraze L 75mg/20mg Capsule SR

Jasrab LS 75mg/20mg Capsule SR
Frequently asked questions
What are the best practices for taking Searab L 75mg/20mg Capsule SR?
Take Searab L 75mg/20mg Capsule SR exactly as directed by your doctor. It is recommended to take one capsule daily on an empty stomach, following the dosing instructions provided by your healthcare professional.
What are the contraindications associated with the use of Searab L 75mg/20mg Capsule SR?
Use of Searab L 75mg/20mg Capsule SR should be avoided in patients with a known allergy to any of its components or excipients.
Can Searab L 75mg/20mg Capsule SR cause dizziness?
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) after taking Searab L 75mg/20mg Capsule SR. If you feel dizzy or lightheaded, it is recommended to rest for a while and resume once you feel better.
Does Searab L 75mg/20mg Capsule SR increase the risk of fractures?
Several studies suggest that treatment with high doses of Searab L 75mg/20mg Capsule SR, especially for prolonged periods (a year or longer) and/or multiple daily doses, may be associated with an increased risk of osteoporosis-related fractures, such as those to the hip, wrist, or spine.
Is it safe to drive while taking Searab L 75mg/20mg Capsule SR?
No, taking Searab L 75mg/20mg Capsule SR may make you feel sleepy, dizzy, or affect your eyesight. Therefore, do not drive or operate machinery until you know how this medicine affects you.
How should I store and dispose of Searab L 75mg/20mg Capsule SR?
Store the capsules in their original packaging, tightly closed. Dispose of any unused medication according to local guidelines and regulations, ensuring that it is not accessible to children, pets, or other individuals.